Raphael Pharmaceutical Inc. (RAPH)

1.0000 0.0000 (0.00%) At close: 10:30AM EDT

Raphael Pharmaceutical Inc.

4 Lui Paster
Tel Aviv-Jaffa 6803605
Israel
972 5 2775 5072
https://www.raphaelpharmaceutical.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Shlomo Pilo	CEO & Chairman	244k	N/A	1955
Mr. Guy Ofir	CFO & Director	144k	N/A	1973
Dr. Igal Louria Hayon	CTO & Director	N/A	N/A	1973

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Raphael Pharmaceutical Inc., a pharmaceutical drug research and development company, focuses on the discovery and clinical development of life-improving drug therapies based on cannabinoids. The company develops product candidate for the treatment of rheumatoid arthritis and hyper inflammatory syndrome inflammation related to COVID-19. It also intends to develop product candidate to treat oncology indications. The company is headquartered in Tel Aviv-Jaffa, Israel.

Corporate governance

Raphael Pharmaceutical Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.